LT3082795T - Omega 3 riebalų rūgščių kompozicijos, skirtos gydyti ligas, kurios sukelia nervų sistemos pažeidimą - Google Patents

Omega 3 riebalų rūgščių kompozicijos, skirtos gydyti ligas, kurios sukelia nervų sistemos pažeidimą

Info

Publication number
LT3082795T
LT3082795T LTEP13830184.1T LT13830184T LT3082795T LT 3082795 T LT3082795 T LT 3082795T LT 13830184 T LT13830184 T LT 13830184T LT 3082795 T LT3082795 T LT 3082795T
Authority
LT
Lithuania
Prior art keywords
omega
compositions
fatty acids
nervous system
treat diseases
Prior art date
Application number
LTEP13830184.1T
Other languages
English (en)
Inventor
Tassos GEORGIOU
Original Assignee
Tassos GEORGIOU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tassos GEORGIOU filed Critical Tassos GEORGIOU
Publication of LT3082795T publication Critical patent/LT3082795T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/08—Food product presented as a kit of parts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/18—Lipids
    • A23V2250/186—Fatty acids
    • A23V2250/1868—Docosahexaenoic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/18—Lipids
    • A23V2250/186—Fatty acids
    • A23V2250/187—Eicosapentaenoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
LTEP13830184.1T 2013-12-19 2013-12-19 Omega 3 riebalų rūgščių kompozicijos, skirtos gydyti ligas, kurios sukelia nervų sistemos pažeidimą LT3082795T (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2013/077356 WO2015090394A1 (en) 2013-12-19 2013-12-19 Compositions of omega 3 fatty acids to treat diseases which involve damage to the nervous system

Publications (1)

Publication Number Publication Date
LT3082795T true LT3082795T (lt) 2020-11-10

Family

ID=50137601

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP13830184.1T LT3082795T (lt) 2013-12-19 2013-12-19 Omega 3 riebalų rūgščių kompozicijos, skirtos gydyti ligas, kurios sukelia nervų sistemos pažeidimą

Country Status (24)

Country Link
US (2) US20160331712A1 (lt)
EP (1) EP3082795B1 (lt)
JP (1) JP6389893B2 (lt)
KR (1) KR101898358B1 (lt)
CN (1) CN105828813A (lt)
AU (1) AU2013407946B2 (lt)
BR (1) BR112016014182A2 (lt)
CA (1) CA2934600C (lt)
CY (1) CY1123942T1 (lt)
DK (1) DK3082795T3 (lt)
ES (1) ES2813383T3 (lt)
HR (1) HRP20201221T1 (lt)
HU (1) HUE050205T2 (lt)
IL (1) IL246254B (lt)
LT (1) LT3082795T (lt)
MX (1) MX2016007803A (lt)
MY (1) MY185412A (lt)
PH (1) PH12016501159A1 (lt)
PL (1) PL3082795T3 (lt)
PT (1) PT3082795T (lt)
RS (1) RS60862B1 (lt)
RU (1) RU2667640C1 (lt)
UA (1) UA117274C2 (lt)
WO (1) WO2015090394A1 (lt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3586640A1 (en) 2018-06-21 2020-01-01 Nuseed Pty Ltd Dha enriched polyunsaturated fatty acid compositions
CN108721269A (zh) * 2018-07-10 2018-11-02 广东海洋大学 一种epa与dha混合剂在防治焦虑和快感缺乏方面的应用
WO2021087399A1 (en) 2019-10-30 2021-05-06 Perfuse Therapeutics, Inc. Treatment of ocular diseases using endothelin receptor antagonists
CA3168810A1 (en) 2020-02-06 2021-08-12 Perfuse Therapeutics, Inc. Compositions for treatment of ocular diseases
EP4329753A1 (en) 2021-04-30 2024-03-06 Perfuse Therapeutics, Inc. Pharmaceutical compositions and intravitreal drug delivery systems for the treatment of ocular diseases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060135610A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Cardiovascular compositions
US20100254951A1 (en) * 2005-02-22 2010-10-07 Mochida Pharmaceutical Co., Ltd. Nerve Regeneration Promoting Agent
CA2598525A1 (en) * 2005-02-22 2006-08-31 Mochida Pharmaceutical Co., Ltd. Nerve regeneration promoting agent
US20070265340A1 (en) * 2006-01-05 2007-11-15 Shalwitz Robert A Treatment of fatty liver
EP1900378A1 (en) 2006-08-31 2008-03-19 Novartis AG Pharmaceutical compositions for the treatment of fungal infections
JPWO2010018856A1 (ja) * 2008-08-13 2012-01-26 持田製薬株式会社 カンナビノイド受容体関連疾患の予防／改善または治療剤
JP5872453B2 (ja) * 2009-04-17 2016-03-01 ナタク ファルマ エセ．エレ． フィタン酸含量が低く、ω−３脂肪酸に富む組成物
US20110021465A1 (en) * 2009-07-23 2011-01-27 U.S. Nutraceuticals, Llc D/B/A Valensa International Synergistic composition and method of retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome
US20110237548A1 (en) * 2009-07-23 2011-09-29 U.S. Nutraceuticals, Llc D/B/A Valensa International Synergistic composition and method of retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome using omega choline
RU2597793C2 (ru) * 2011-01-25 2016-09-20 Нестек С.А. Способы и композиции для лечения, ослабления или предотвращения ухудшения зрительной системы животных
CN103764136A (zh) * 2011-02-18 2014-04-30 雀巢产品技术援助有限公司 用于治疗、减轻或预防动物神经***损害的方法和组合物
WO2012125020A1 (en) * 2011-03-14 2012-09-20 N.V. Nutricia Method for treating neurotrauma
JP2016508955A (ja) * 2011-09-12 2016-03-24 ジョルジオ タソスＧＥＯＲＧＩＯＵ， Ｔａｓｓｏｓ 疾病治療用オメガ脂肪酸の使用

Also Published As

Publication number Publication date
WO2015090394A1 (en) 2015-06-25
UA117274C2 (uk) 2018-07-10
AU2013407946A1 (en) 2016-08-04
KR101898358B1 (ko) 2018-09-12
CN105828813A (zh) 2016-08-03
DK3082795T3 (da) 2020-08-24
CA2934600C (en) 2018-11-20
EP3082795B1 (en) 2020-05-20
JP6389893B2 (ja) 2018-09-12
HRP20201221T1 (hr) 2020-11-13
US20190192466A1 (en) 2019-06-27
AU2013407946A2 (en) 2016-08-25
IL246254B (en) 2021-04-29
RU2667640C1 (ru) 2018-09-21
AU2013407946B2 (en) 2017-09-07
IL246254A0 (en) 2016-07-31
PH12016501159A1 (en) 2016-08-15
PL3082795T3 (pl) 2020-11-16
EP3082795A1 (en) 2016-10-26
CY1123942T1 (el) 2022-03-24
US10905671B2 (en) 2021-02-02
MY185412A (en) 2021-05-18
HUE050205T2 (hu) 2020-11-30
BR112016014182A2 (pt) 2017-08-08
KR20160093729A (ko) 2016-08-08
RU2016129079A (ru) 2018-01-24
JP2017501169A (ja) 2017-01-12
RS60862B1 (sr) 2020-11-30
PT3082795T (pt) 2020-08-27
ES2813383T3 (es) 2021-03-23
CA2934600A1 (en) 2015-06-25
MX2016007803A (es) 2017-08-10
US20160331712A1 (en) 2016-11-17

Similar Documents

Publication Publication Date Title
ZA201603734B (en) Removal of free fatty acids from glyceride oils
HK1205096A1 (en) Method for the preparation of triglycerides of medium-chain length fatty acids
IL246254B (en) Compounds of omega-3 fatty acids for the treatment of diseases involving damage to the nervous system
EP2809317A4 (en) FATTY ACIDS AS ANTI-INFLAMMATORY AGENTS
SG10201507002PA (en) Production Of Fatty Acids Esters
ZA201402318B (en) Use of omega fatty acids for treating disease
IL252674A0 (en) Production of transgenic canola with little or no saturated fatty acids
RS59523B1 (sr) Smeša masnih kiselina za primenu u lečenju inflamatornih patologija
PL2860256T3 (pl) Sposób wytwarzania L-aminokwasów
EP3318261A4 (en) Use of zoledronic acid to prepare drug treating fatty liver disease
HK1244218A1 (zh) 包括多不飽和游離脂肪酸的毫米膠囊配製品
HK1216614A1 (zh) 治療脂肪肝疾病的方法
DK3305755T3 (da) Ny fremgangsmåde til at fremstille stærkt umættede fedtsyreestere
PL2958885T3 (pl) Sposób wytwarzania estru kwasu bursztynowego
IL245199A0 (en) Processes for the preparation of unsaturated esters
GB2528618B (en) Chromatographic process for the production of highly purified polyunsaturated fatty acids
EP3027180A4 (en) Compositions and methods of the treatment of fatty acid metabolism disorders
EP2964772A4 (en) PREPARATION OF OMEGA-3 FATTY ACIDS FROM PYTHIUM SPECIES
PL3079684T3 (pl) Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna
TH1301005844B (th) กระบวนการสำหรับเอสเทอริฟิเคชันแบบเร่งปฏิกิริยาได้เองของกรดไขมัน